SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 120.01 |
| Enterprise Value ($M) | 80.52 |
| Book Value ($M) | 71.00 |
| Book Value / Share | 1.19 |
| Price / Book | 1.69 |
| NCAV ($M) | 70.47 |
| NCAV / Share | 1.18 |
| Price / NCAV | 1.70 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.65 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.59 |
| Current Ratio | 5.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 104.07 |
| Assets | 104.61 |
| Liabilities | 33.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -60.12 |
| Net Income | -55.85 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -43.21 |
| Cash from Investing | -44.92 |
| Cash from Financing | -0.17 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 8.20 | -47.44 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 291,953 | 1,724,323 | 16.93 | |
| 247,291 | 1,257,756 | 19.66 | |
| 459,014 | 1,987,363 | 23.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AKAN – Akanda Corp. | AKBA – Akebia Therapeutics, Inc. |
| ALBT – Avalon GloboCare Corp. | ALGS – Aligos Therapeutics, Inc. |
| ALTS – JanOne Inc. |
Financial data and stock pages provided by
Fintel.io